Moreover, oAd-CD47 significantly decreased the number of MDSCs and Tregs in the TME and effectively reversing the increased expression of PD-1 and Tim-3 on CD8+T cells, thereby enhancing anti-tumor T cell responses. The gene discussed is CD8A; the disease is neoplasm.